Praxis Precision Medicines (PRAX) Change in Account Payables (2019 - 2026)

Praxis Precision Medicines' Change in Account Payables history runs 8 years deep, the most recent figure standing at $6.5 million for Q1 2026.

• On a quarterly basis, Change in Account Payables fell 37.1% year-over-year to $6.5 million in Q1 2026; TTM through Mar 2026 was $8.2 million, a 38.94% decrease from a year earlier, with the FY2025 full-year figure at $12.1 million, up 80.2% from the prior year.
• Change in Account Payables rose to $6.5 million in Q1 2026 per PRAX's latest filing, from -$6.2 million in the prior quarter.
• Across five years, Change in Account Payables topped out at $10.4 million in Q1 2025 and bottomed at -$9.0 million in Q2 2023.
• The 5-year median for Change in Account Payables is $2.0 million (2025), against an average of $1.2 million.
• Across the five-year window, Change in Account Payables sank 626.01% in 2022 and surged 883.67% in 2024, its largest moves.
• Year by year, Change in Account Payables stood at $4.6 million in 2022, then slumped by 128.55% to -$1.3 million in 2023, then tumbled by 91.07% to -$2.5 million in 2024, then tumbled by 149.56% to -$6.2 million in 2025, then surged by 205.42% to $6.5 million in 2026.
• Per Business Quant, the three latest PRAX Change in Account Payables figures stand at $6.5 million (Q1 2026), -$6.2 million (Q4 2025), and $2.0 million (Q3 2025).